Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,350,142 | 1,146,373 | 711,399 | 615,097 | 573,823 |
| Marketable Securities | 38,366 | 265,333 | 504,340 | 425,927 | 412,942 |
| Receivables | 891,145 | 938,855 | 846,530 | 888,113 | 792,129 |
| Inventories | 494,102 | 335,540 | 331,624 | 372,171 | 368,019 |
| Other current assets | 229,931 | 167,712 | 159,854 | 201,958 | 180,922 |
| TOTAL | $3,003,686 | $2,853,813 | $2,553,747 | $2,503,267 | $2,327,835 |
| Non-Current Assets | |||||
| PPE Net | 697,759 | 722,789 | 802,308 | 997,966 | 1,070,340 |
| Investments And Advances | 636,913 | 2,031,188 | 2,374,394 | 2,246,858 | 2,620,683 |
| Intangibles | 2,318,099 | 395,287 | 511,592 | 576,133 | 661,027 |
| Other Non-Current Assets | 366,254 | 301,240 | 287,992 | 254,683 | 340,430 |
| TOTAL | $4,019,024 | $3,450,504 | $3,976,286 | $4,075,639 | $4,692,480 |
| Total Assets | $7,022,704 | $6,304,309 | $6,530,034 | $6,578,907 | $7,020,315 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 198,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 589,571 | 418,768 | 494,276 | 442,232 | 368,132 |
| Other current liabilities | 143,425 | 127,857 | 141,118 | 110,449 | 314,900 |
| TOTAL | $978,754 | $715,006 | $909,675 | $586,741 | $881,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 693,000 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 76,633 | 71,512 | 77,863 | 92,809 | 101,774 |
| TOTAL | $841,810 | $78,929 | $86,543 | $103,267 | $112,339 |
| Total Liabilities | $1,820,570 | $793,935 | $996,225 | $690,008 | $993,439 |
| Shareholders' Equity | |||||
| Common Shares | 114,563 | 119,770 | 128,449 | 154,486 | 163,165 |
| Retained earnings | 5,219,993 | 5,300,463 | 5,253,186 | 5,738,311 | 5,483,612 |
| Other shareholders' equity | 168,361 | 405,675 | 426,782 | 507,656 | 638,127 |
| TOTAL | $5,202,140 | $5,510,368 | $5,533,809 | $5,888,898 | $6,026,876 |
| Total Liabilities And Equity | $7,022,710 | $6,304,303 | $6,530,034 | $6,578,906 | $7,020,315 |